Search research articles
Contact Us
Filters
Showing results (1-10 of 60) with videos related to
Page
of 6
Sort By:
Current Opinion in Nephrology and Hypertension
|
April 11, 2000
Renal endothelin in hypertension
D M Pollock
Current Opinion in Investigational Drugs (London, England : 2000)
|
September 22, 2001
Endothelin antagonists in the treatment of renal failure
D M Pollock
Physiological Genomics
|
June 8, 2001
Contrasting pharmacological ETB receptor blockade with genetic ETB deficiency in renal responses to big ET-1
D M Pollock
Clinical and Experimental Pharmacology & Physiology
|
March 19, 1999
Chronic studies on the interaction between nitric oxide and endothelin in cardiovascular and renal function
D M Pollock
Journal of the American Society of Nephrology : JASN
|
January 19, 1999
Combined treatment with ibuprofen and the AT1 receptor antagonist candesartan in young spontaneously hypertensive rats
D M Pollock, P Morsing
The American Journal of Physiology
|
October 29, 1998
Hypertensive response to chronic NO synthase inhibition is different in Sprague-Dawley rats from two suppliers
D M Pollock, A Rekito
American Journal of Physiology. Renal Physiology
|
June 16, 2001
Evidence for endothelin involvement in the response to high salt
D M Pollock, J S Pollock
The American Journal of Physiology
|
March 1, 1990
Tubuloglomerular feedback and blood flow autoregulation during DA1-induced renal vasodilation
D M Pollock, W J Arendshorst
The American Journal of Physiology
|
January 1, 1990
Native tubular fluid attenuates ANF-induced inhibition of tubuloglomerular feedback
D M Pollock, W J Arendshorst
The American Journal of Physiology
|
October 1, 1991
Effect of acute renal denervation and ANF on renal function in adult spontaneously hypertensive rats
D M Pollock, W J Arendshorst
Page
of 6
Search research articles
Search
Showing results (1-10 of 60) with videos related to
Sort By:
Page
of 6
Current Opinion in Nephrology and Hypertension
|
April 11, 2000
Renal endothelin in hypertension
D M Pollock
Current Opinion in Investigational Drugs (London, England : 2000)
|
September 22, 2001
Endothelin antagonists in the treatment of renal failure
D M Pollock
Physiological Genomics
|
June 8, 2001
Contrasting pharmacological ETB receptor blockade with genetic ETB deficiency in renal responses to big ET-1
D M Pollock
Clinical and Experimental Pharmacology & Physiology
|
March 19, 1999
Chronic studies on the interaction between nitric oxide and endothelin in cardiovascular and renal function
D M Pollock
Journal of the American Society of Nephrology : JASN
|
January 19, 1999
Combined treatment with ibuprofen and the AT1 receptor antagonist candesartan in young spontaneously hypertensive rats
D M Pollock, P Morsing
The American Journal of Physiology
|
October 29, 1998
Hypertensive response to chronic NO synthase inhibition is different in Sprague-Dawley rats from two suppliers
D M Pollock, A Rekito
American Journal of Physiology. Renal Physiology
|
June 16, 2001
Evidence for endothelin involvement in the response to high salt
D M Pollock, J S Pollock
The American Journal of Physiology
|
March 1, 1990
Tubuloglomerular feedback and blood flow autoregulation during DA1-induced renal vasodilation
D M Pollock, W J Arendshorst
The American Journal of Physiology
|
January 1, 1990
Native tubular fluid attenuates ANF-induced inhibition of tubuloglomerular feedback
D M Pollock, W J Arendshorst
The American Journal of Physiology
|
October 1, 1991
Effect of acute renal denervation and ANF on renal function in adult spontaneously hypertensive rats
D M Pollock, W J Arendshorst
Page
of 6